Abstract:Background Casticin (CAS), a natural flavonoid found in Viticis Fructus, Viticis Cannabifoliae Fructus , and Semen Euphorbiae , shows anti-inflammatory activity and efficacy against various cancers. However, its effect on stemness associated with self-renewal in cervical cancer (CC) cells remains unclear, as well as the underlying mechanism. Purpose The primary objective of this study was to examine the effect of CAS on CC stemness and to explore the underpinning regulatory mechanism. Methods HeLa cells underwent treatment with varying concentrations of CAS (0, 10, 30, 100 nM). To evaluate the impacts of CAS on CC stemness and tumorigenicity, sphere- and colony-formation assays and a xenograft model were employed. The study involved screening for changes in miRNAs and their target genes. The miRNA array identified an upregulation in miRNAs, whereas the mRNA array detected a downregulation of specific target genes. The latter genes were found to regulate stem cell-related genes through miR-342-3p in HeLa cells administered CAS. Next, whether miR-342-3p directly targets FOXM1 when upregulated by CAS was assessed by the luciferase reporter assay. qRT-PCR was performed to analyze miR-342-3p expression. Additionally, immunoblotting was conducted to assess the protein amounts of FoxM1 and stemness-related factors (CD133, CD49f, Nanog, and Sox2). Function rescue experiments were conducted to determine the mechanism of CAS in stemness regulation. These experiments involved utilizing a miR-342-3p inhibitor and overexpressing FOXM1 in HeLa cells. Results CAS decreased in vitro stemness, suppressing sphere- and colony-formation capabilities of CC. It also dose-dependently downregulated the expression of stemness-associated proteins, including CD133, CD49f, Nanog, and Sox2. Moreover, CAS inhibited in vivo carcinogenesis, remarkably reducing tumor growth in mice bearing HeLa cell xenografts. Analysis revealed downregulated FOXM1 expression in HeLa cells treated with CAS. In the luciferase reporter assay, miR-342-3p was found to directly target FOXM1 in CAS-treated HeLa cells. Additionally, miR-342-3p inhibitor transfection successfully rescued CAS' suppressive impact on stemness. Furthermore, overexpression of FOXM1 did not induce changes in miR-342-3p expression. However, it effectively rescued CAS' suppressive effects on stemness. Moreover, CAS also inhibited stemness, upregulated miR-342-3p , and lowered FOXM1 expression in the SiHa cell line. Conclusion CAS suppresses self-renewal-associated stemness by targeting FOXM1 via miR-342-3p upregulation. These findings suggest CAS is promising as a novel therapeutic candidate in CC.

Casticin impairs cell growth and induces cell apoptosis via cell cycle arrest in human oral cancer SCC-4 cells.

Casticin induced apoptotic cell death and altered associated gene expression in human colon cancer colo 205 cells.

Casticin induces leukemic cell death through apoptosis and mitotic catastrophe

Apoptosis Was Induced by Casticin in Acute Myelocytic Leukemia Cells

Casticin Induces DNA Damage and Inhibits DNA Repair-Associated Protein Expression in B16F10 Mouse Melanoma Cancer Cells.

Casticin Induced Apoptosis in A375.S2 Human Melanoma Cells Through the Inhibition of NF-κB and Mitochondria-Dependent Pathways in Vitro and Inhibited Human Melanoma Xenografts in a Mouse Model in Vivo

Casticin Induces DNA Damage and Affects DNA Repair Associated Protein Expression in Human Lung Cancer A549 Cells (Running Title: Casticin Induces DNA Damage in Lung Cancer Cells)

Casticin Induces Apoptosis and G0/G1 Cell Cycle Arrest in Gallbladder Cancer Cells

Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells.

Casticin Induces DNA Damage and Impairs DNA Repair in Human Bladder Cancer TSGH-8301 Cells

Casticin Impairs Cell Migration and Invasion of Mouse Melanoma B16F10 Cells Via PI3K/AKT and NF‐κB Signaling Pathways

Casticin Inhibits Human Prostate Cancer DU 145 Cell Migration and Invasion Via Ras/Akt/NF-κB Signaling Pathways.

Synergistic Apoptotic Effect of Crocin and Cisplatin on Osteosarcoma Cells Via Caspase Induced Apoptosis.

Casticin Inhibits A375.S2 Human Melanoma Cell Migration/Invasion Through Downregulating NF-κB and Matrix Metalloproteinase-2 and -1.

The role of casticin in the apoptosis of pancreatic cancer cells and its mechanism

Casticin inhibits the hedgehog signaling and leads to apoptosis in AML stem-like KG1a and mature KG1 cells

Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.

Casticin induces ferroptosis in human osteosarcoma cells through Fe2+ overload and ROS production mediated by HMOX1 and LC3-NCOA4

Casticin Promotes Immune Responses, Enhances Macrophage and NK Cell Activities, and Increases Survival Rates of Leukemia BALB/c Mice.

Induction of Apoptosis in Human Cervical Cancer HeLa Cells by Casticin

Casticin suppresses self-renewal related stemness via miR-342-3p-mediated FoxM1 downregulation in cervical cancer cells